Robert P. Baughman MD
Critical Care Medicine, Pleural Disease
Professor, Internal Medicine, University of Cincinnati College of Medicine
Join to view full profile
222 Piedmont AvenueSuite 4000Cincinnati, OH 45219
Phone+1 513-475-8523
Dr. Baughman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1982 - 1983- University of Cincinnati Medical Center/College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1982
- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1977 - 1980
Case Western Reserve University School of MedicineClass of 1977
Certifications & Licensure
OH State Medical License 1978 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
Publications & Presentations
PubMed
- 3 citationsWASOG Clinical Trial Endpoint Task Force: Executive Summary.Robert P Baughman, Elyse E Lower, Daniel A Culver, Marc A Judson, Athol U Wells
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2025-09-30 - 1 citationsAirway involvement in pulmonary sarcoidosis: Clinical and CT features.Ying Zhou, Qian Yao, Xianqiu Chen, Dong Yu, Bing Jie
Respiratory Medicine. 2025-09-01 - 2 citationsMethotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis?Robert P Baughman, Elyse E Lower
The New England Journal of Medicine. 2025-07-17
Press Mentions
Methotrexate Proves Its Mettle as First-Line Therapy for Pulmonary SarcoidosisMay 18th, 2025- aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung DiseasesMarch 30th, 2023
- Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial ResultsAugust 15th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
